-
Mashup Score: 0Nurse-Led Gout Care Linked to Better Medication Adherence - 6 day(s) ago
Among the nurse-led cohort, 83% of patients with gout achieved target p-urate levels and 98% continued treatment with urate lowering therapy.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Study Highlights Deficiencies in Medication Adherence Information, Strategies for Gout - 8 day(s) ago
Strategies designed to promote medication adherence were found in only 1 out of 3 websites.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Background/Purpose Little is known about long-term clinical outcomes or urate-lowering (ULT) therapy use following pegloticase discontinuation. We examined ULT use, serum urate (SU), inflammatory biomarkers, and renal function following pegloticase discontinuation. Methods We conducted a retrospective analysis of gout patients who discontinued pegloticase using the Rheumatology Informatics System for Effectiveness (RISE) registry from 1/2016 to 6/2022. We defined discontinuation as a gap ≥ 12 weeks after last infusion. We examined outcomes beginning two weeks after last dose and identified ULT therapy following pegloticase discontinuation. We evaluated changes in lab values (SU, eGFR, CRP and ESR), comparing on- treatment (≤ 15 days of the second pegloticase dose) to post-treatment. Results Of the 375 gout patients discontinuing pegloticase, median (IQR) laboratory changes following discontinuation were: SU: +2.4 mg/dL (0.0,6.3); eGFR: -1.9 mL/min (− 8.7,3.7); CRP: -0.8 mg/L (-12.8,0.0
Categories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2Virtual Events | KRYSTEXXA (pegloticase) - 24 day(s) ago
Join live, interactive discussions with gout specialists and real KRYSTEXXA patients who can answer your most pressing questions. See safety info.
Source: www.krystexxa.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
Alkaline water significantly reduced VAS pain scores among patients with gout.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Patients with gout who had poor health literacy were more likely to experience ≥ 2 flares within the previous 12 months.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 22The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in people with gout - 1 month(s) ago
Nature Reviews Rheumatology – Gout is associated with various cardiometabolic–renal comorbidities that increase the risk of mortality. Sodium–glucose cotransporter type 2 (SGLT2)…
Source: www.nature.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 1If You Have Gout, You May Benefit From More Exercise - 1 month(s) ago
Learn about the benefits of exercise for gout, including fewer flare-ups and better joint health.
Source: www.henryford.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4SGLT2 Inhibitors Could Play a Role in Treating Gout - 1 month(s) ago
A new review considers how SGLT2 inhibitors like dapagliflozin and empagliflozin have been shown to clinically improve gout while reducing its cardiometabolic and renal comorbidities.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 35The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in people with gout - 1 month(s) ago
Nature Reviews Rheumatology – Gout is associated with various cardiometabolic–renal comorbidities that increase the risk of mortality. Sodium–glucose cotransporter type 2 (SGLT2)…
Source: www.nature.comCategories: General Medicine News, RheumatologyTweet
Using a targeted approach, nurse-led #gout care was linked to a higher uptake of and adherence to urate lowering therapy compared with usual care. Learn more: https://t.co/RWqqD3gBkF